Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ SuspendedNot ApplicableIIT A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of LT010 in preventing hair loss
/ RecruitingNot ApplicableIIT Clinical trial of the safety and efficacy of LT010 in preventing hair loss
100 Clinical Results associated with Chengdu Lingtai Ke Biotechnology Co., Ltd.
0 Patents (Medical) associated with Chengdu Lingtai Ke Biotechnology Co., Ltd.
100 Deals associated with Chengdu Lingtai Ke Biotechnology Co., Ltd.
100 Translational Medicine associated with Chengdu Lingtai Ke Biotechnology Co., Ltd.